Davis, CA, United States of America

Gaomai Yang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Gaomai Yang: Innovator in Oligonucleotide Synthesis

Introduction

Gaomai Yang is a prominent inventor based in Davis, CA, known for his significant contributions to the field of oligonucleotide synthesis. With a total of four patents to his name, Yang has made strides in developing methods and compounds that enhance the efficiency of liquid phase oligonucleotide synthesis.

Latest Patents

Yang's latest patents include innovative approaches to oligonucleotide synthesis. One of his notable patents is focused on "Compounds and methods for liquid phase oligonucleotide synthesis." This patent discusses methods and compounds that utilize small molecules with lipophilic groups to improve the synthesis process. Another significant patent is titled "Compositions and methods for liquid phase oligonucleotide synthesis," which relates to polymers used as polymeric polyvalent hubs for the same purpose. These advancements are crucial for the development of more efficient oligonucleotide synthesis techniques.

Career Highlights

Gaomai Yang is associated with Hongene Biotech Corporation, where he applies his expertise in oligonucleotide synthesis. His work has been instrumental in advancing the methodologies used in this field, contributing to both academic research and practical applications.

Collaborations

Yang collaborates with notable colleagues, including David Yu and Yun-Chiao Yao. Their combined efforts in research and development have further propelled advancements in oligonucleotide synthesis.

Conclusion

Gaomai Yang's innovative work in oligonucleotide synthesis has established him as a key figure in the field. His patents reflect a commitment to enhancing synthesis methods, which can have far-reaching implications in biotechnology and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…